Intervention not reported
Cramp frequency (percentage change from baseline at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (percentage change from baseline at 4 weeks) (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (mean number of cramps per week on treatment at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review
Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · pregnant women with leg cramps
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cramp duration (≥ 1 minute at 4 weeks) · pregnant women with leg cramps
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cramp frequency (responder analysis: 25% or better reduction at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (responder analysis: 25% or better reduction at 4… (high certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (mean number of cramps per week on treatment at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (mean number of cramps per week on treatment at 4… (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp intensity (moderate or worse at 4 weeks) (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp duration (≥ 1 minute at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp duration (≥ 1 minute at 4 weeks) (low certainty).
1 finding from 1 review
Intervention not reported
Major adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
It is very uncertain whether the intervention changes major adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in minor adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (percentage change from baseline at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review
Intervention not reported
Cramp frequency (responder analysis: 25% or better reduction at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review